ATP5C1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.919000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.537400E-01
Normal-vs-Stage2
9.122600E-01
Normal-vs-Stage3
9.387200E-01
Normal-vs-Stage4
6.785200E-01
Stage1-vs-Stage2
5.215800E-01
Stage1-vs-Stage3
7.679000E-01
Stage1-vs-Stage4
5.234600E-01
Stage2-vs-Stage3
9.636400E-01
Stage2-vs-Stage4
5.768400E-01
Stage3-vs-Stage4
7.433600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.117000E-01
Normal-vs-AfricanAmerican
8.695000E-01
Normal-vs-Asian
6.649000E-01
Caucasian-vs-AfricanAmerican
6.789000E-01
Caucasian-vs-Asian
5.791800E-01
AfricanAmerican-vs-Asian
2.906200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.159600E-01
Normal-vs-Female
8.734400E-01
Male-vs-Female
7.589800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.082400E-01
Normal-vs-Age(41-60Yrs)
9.384200E-01
Normal-vs-Age(61-80Yrs)
8.515400E-01
Normal-vs-Age(81-100Yrs)
8.103400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.024800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.003600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.765600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.577600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.960400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.946600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.532800E-01
Normal-vs-Daily Drinker
9.020000E-01
Normal-vs-Weekly Drinker
8.424800E-01
Normal-vs-Occasional Drinker
6.929800E-01
Normal-vs-Social Drinker
5.637000E-01
Non Drinker-vs-Daily Drinker
6.976600E-01
Non Drinker-vs-Weekly Drinker
7.725000E-01
Non Drinker-vs-Occasional Drinker
3.908200E-01
Non Drinker-vs-Social Drinker
2.381800E-01
Daily Drinker-vs-Weekly Drinker
5.318800E-01
Daily Drinker-vs-Occasional Drinker
6.941800E-01
Daily Drinker-vs-Social Drinker
4.863800E-01
Weekly Drinker-vs-Occasional Drinker
3.398800E-01
Weekly Drinker-vs-Social Drinker
2.181200E-01
Occasional Drinker-vs-Social Drinker
6.736600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.686010E-01
Normal-vs-Grade 2
6.378100E-02
Normal-vs-Grade 3
4.334300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.931600E-02
Grade 1-vs-Grade 3
1.984440E-01
Grade 1-vs-Grade 4
1.686010E-01
Grade 2-vs-Grade 3
6.493600E-01
Grade 2-vs-Grade 4
6.378100E-02
Grade 3-vs-Grade 4
4.334300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.077800E-01
Normal-vs-NonDiabetic
9.330600E-01
Diabetic-vs-NonDiabetic
6.914200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.695600E-01
Normal-vs-NoPancreatitis
8.826400E-01
Pancreatitis-vs-NoPancreatitis
5.013600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.714400E-01
Normal-vs-N1
9.030200E-01
N0-vs-N1
5.764400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.827400E-01
Normal-vs-TP53-NonMutant
7.806800E-01
TP53-Mutant-vs-TP53-NonMutant
7.761600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
